SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Can-Fite BioPharma (CANF)

CANF RSS Feed
Add CANF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/18/2017 12:34:31 PM - Followers: 44 - Board type: Free - Posts Today: 1

Can-Fite BioPharma (TASE: CFBI, OTC: CANFY) is an Israeli biopharmaceutical company with fully integrated pharmaceutical
discovery and clinical development capabilities.
The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address
autoimmune-inflammatory and cancer diseases.

Can-Fite has a number of drugs in various stages of research and development. The pipeline drugs are synthetic, highly specific
agonists and an allosteric modulator, all target the A3 adenosine receptor. All drugs are orally bioavailable with an excellent safety profile.
CF101, Can-Fite's lead compound, is an oral drug that has been successfully tested in animal models and is currently in advanced stages
of clinical development for Rheumatoid Arthritis (RA) and Psoriasis. All human clinical studies have demonstrated this drug to have an
excellent safety profile. Phase IIa study data in RA indicates that CF101 has disease modifying anti-inflammatory activity in RA patients
failing methotrexate therapy. The Phase II clinical study in Psoriasis was successfully concluded showing efficacy of CF101, thereby
establishing the basis for further clinical development.

Israeli Office

10 Bareket Street
Kiryat Matalon
P.O. Box 7537
Petah-Tikva 49170
ISRAEL

Tel: +972-3-9241114
Fax: +972-3-9249378

General email:
info@canfite.co.il
Press Inquiries

Gelbart Kahana Investor Relations
Tel: +972-3-6074717

USA Office

1000 Winter St., Suite 2000
Waltham
MA 02451
USA
Tel: +972-3-9241114
Fax: +972-3-9249378


General email: info@canfite.com


http://www.canfite.com/
SureTrader
Interactive Brokers Advertisement
CANF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CANF News: Report of Foreign Issuer (6-k) 07:25 AM
CANF News: Can-Fite Reports on the Progress of Its Phase II Liver Cancer with Namodenoson 07:00 AM
CANF News: Report of Foreign Issuer (6-k) 11/27/2017 07:47:13 AM
CANF News: Can-Fite Reports Third Quarter 2017 Financial Results & Provides Clinical Update 11/27/2017 07:30:00 AM
CANF News: Report of Foreign Issuer (6-k) 11/27/2017 07:06:46 AM
News News Alert: Report of Foreign Issuer (6-k) 12/18/2017 07:25:29 AM
PostSubject
#1120   News is out on Liver drug , up Pan Am 12/18/17 12:34:31 PM
#1119   test BIOChecker4 12/05/17 09:55:47 AM
#1118   Up 14% in after hours on news! Pan Am 08/23/17 08:26:23 PM
#1117   Low volume penny stock...no support...heading to retest all maddog27 08/03/17 03:32:27 PM
#1116   Looks like someone is buying everyday, Pan Am 07/29/17 11:16:27 AM
#1115   Doesn't look like 1.60 is in the cards. maddog27 07/27/17 09:55:03 PM
#1114   Reason for spike today? maddog27 05/11/17 03:11:46 PM
#1113   CANF-"Piclidenoson has demonstrated its safety profile in over Chemist823 04/25/17 11:44:39 AM
#1112   I was ball parking it, may only be Chemist823 04/25/17 09:39:38 AM
#1111   Easy 20 bagger?! Now that's a bold prediction. scottsmith 04/25/17 08:40:20 AM
#1110   It looks like the market agrees. up 25%+ PM steamerstocks 04/25/17 08:36:30 AM
#1109   CANF-Easy 20 bagger, way over sold and under Chemist823 04/25/17 08:02:47 AM
#1108   If u look for solid science Israeli biotech Oren1976 03/31/17 08:23:51 AM
#1107   That's the question, whether there will be more Chemist823 03/29/17 11:46:29 AM
#1106   Hi, Been looking at this one for over a Spideyboy 03/27/17 07:11:46 AM
#1105   Keeps going down ... yikes Pan Am 03/15/17 08:01:15 PM
#1104   Preclinical is a very midastouch017 03/01/17 02:38:52 AM
#1103   Was hoping for an up tick ... this Pan Am 02/28/17 06:04:44 PM
#1102   crazy how this is only up by a [SMART MONEY] 02/28/17 09:59:24 AM
#1101   CANF: Ready to Start Two Phase III Trials midastouch017 02/23/17 01:46:05 PM
#1100   surprised not more volume,, looks good. blulotus 02/08/17 04:33:48 PM
#1099   Can-Fite Gears Up for ACRobat, its Phase III midastouch017 02/08/17 07:26:52 AM
#1098   Maybe another Pharm getting in at a deep discount? Pan Am 01/19/17 12:17:02 PM
#1097   Well, it keeps them floating! midastouch017 01/19/17 11:14:38 AM
#1096   So is this good or bad... long run? Pan Am 01/19/17 11:05:36 AM
#1095   The reason for the drop: midastouch017 01/19/17 08:10:59 AM
#1094   Yep. Just wouldn't have surprised me... alwaysontop 01/18/17 04:38:52 PM
#1093   Nowhere near green. Anythinggi 01/18/17 04:24:39 PM
#1092   It may not, but wouldn't surprise me at alwaysontop 01/18/17 03:33:33 PM
#1091   It refers to a particular type of stock alwaysontop 01/18/17 03:16:07 PM
#1090   With all that buying, and the midastouch017 01/18/17 03:07:41 PM
#1089   That, or someone buying a ton of em alwaysontop 01/18/17 03:01:16 PM
#1088   Highly irregular indeed! midastouch017 01/18/17 01:23:54 PM
#1087   Why all the volume today? Thoughts?? alwaysontop 01/18/17 11:03:32 AM
#1086   Celgene's Otezla Will Survive Against Can-Fite's Piclidenoson midastouch017 01/17/17 12:39:35 PM
#1085   Can-Fite Receives IRB Approval to Commence Patient Enrollment midastouch017 01/09/17 08:33:01 AM
#1084   Can-Fite Receives $500,000 Payment as Part of $3 midastouch017 12/21/16 08:08:04 AM
#1083   Can-Fite Reports Financial Results for Nine Months Ended midastouch017 11/25/16 08:49:09 AM
#1082   Can-Fite Receives Notice of Allowance From U.S. Patent midastouch017 11/09/16 07:46:05 AM
#1081   Can-Fite to Participate in BIO-Europe Partnering Conference on midastouch017 11/07/16 08:05:19 AM
#1080   Can-Fite Signs Distribution Deal for Liver Cancer Drug midastouch017 10/25/16 08:14:04 AM
#1079   Can-Fite Submits Protocol for Phase II Trial of midastouch017 10/13/16 08:13:06 AM
#1078   NASH event today to inform investors midastouch017 10/05/16 11:47:59 AM
#1077   BTW, i do not particularly like midastouch017 09/29/16 11:37:38 AM
#1076   All true—it was the Dirks 1973 case that DewDiligence 09/29/16 11:37:21 AM
#1075   About Ray Dirks (from the article): midastouch017 09/29/16 11:26:14 AM
#1074   Inasmuch as your CANF post is from Ray DewDiligence 09/29/16 11:16:32 AM
#1073   Allergan's $1.7 Billion Acquisition of Tobira for NASH midastouch017 09/29/16 09:12:22 AM
#1072   CF102 currently preparing Phase II trial in NASH zino 09/25/16 04:20:55 PM
#1071   CANF Website, http://ir.canfite.com/ zino 09/22/16 11:57:37 PM
PostSubject